These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Treatment of depressive states and presenile psychiatric disorders]. Bornstein S; Kannas S; Sere de Rivières H; Bureau D; Postel J Therapeutique; 1970 Oct; 46(8):781-4. PubMed ID: 5458909 [No Abstract] [Full Text] [Related]
4. [The present state of drug treatment of depression]. Kielholz P Nervenarzt; 1966 Mar; 37(3):118-21. PubMed ID: 5965686 [No Abstract] [Full Text] [Related]
5. The impact of psychopharmacology on medicine and psychiatry. Garber RS Psychosomatics; 1970; 11(5):386-90. PubMed ID: 5470659 [No Abstract] [Full Text] [Related]
6. [Therapeutic trials with pertofran (G. 35-020) in depressive states]. Bohard F; Le Borgne Y; Guennoc A; Klein H; Masanes P Ann Med Psychol (Paris); 1967 Mar; 125(3):447-51. PubMed ID: 6059935 [No Abstract] [Full Text] [Related]
7. [Therapeutic value of Hydrosarpan 711 in depressive states and psychiatric pathology of the presenium]. Bornstein S; Kannas S; Sere de Rivières H; Bureau D; Postel J Ann Med Psychol (Paris); 1970 Oct; 2(3):433-44. PubMed ID: 5481459 [No Abstract] [Full Text] [Related]
8. [A method of developing and testing new antidepressants]. Poeldinger W Nervenarzt; 1966 Mar; 37(3):121-3. PubMed ID: 6007512 [No Abstract] [Full Text] [Related]
9. Psychopharmacology of the aging. Linton PH Ala J Med Sci; 1980 Apr; 17(2):155-9. PubMed ID: 7416428 [No Abstract] [Full Text] [Related]
10. [Treatment of depression secondary to psychotic disorders]. Sechter D; Vandel P Encephale; 1999 Nov; 25 Spec No 3():40-3. PubMed ID: 10598293 [TBL] [Abstract][Full Text] [Related]
11. The Psychopharmacology Algorithm Project at the Harvard South Shore Program: an update on psychotic depression. Hamoda HM; Osser DN Harv Rev Psychiatry; 2008; 16(4):235-47. PubMed ID: 18661366 [TBL] [Abstract][Full Text] [Related]
12. Problems of differential indications in psychopharmacotherapy. Kühne GE Ther Hung; 1966; 14(4):129-34. PubMed ID: 5963795 [No Abstract] [Full Text] [Related]
13. [Study of the action of thioridazine in various chronic depressive and dissociative psychoses]. Soulairac A; Geier S; De Mijolla A; Berouti R Ann Med Psychol (Paris); 1967 Feb; 125(2):258-67. PubMed ID: 6050432 [No Abstract] [Full Text] [Related]
16. Combination therapy with amisulpride and antidepressants: clinical observations in case series of elderly patients with psychotic depression. Politis AM; Papadimitriou GN; Theleritis CG; Psarros C; Soldatos CR Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jul; 32(5):1227-30. PubMed ID: 18442877 [TBL] [Abstract][Full Text] [Related]
17. Recovery-oriented psychopharmacology: redefining the goals of antipsychotic treatment. Noordsy DL; Torrey WC; Mead S; Brunette M; Potenza D; Copeland ME J Clin Psychiatry; 2000; 61 Suppl 3():22-9. PubMed ID: 10724130 [TBL] [Abstract][Full Text] [Related]
18. [On the clinicoppsychiatric treatment with Benperidol]. Schwarz H Med Welt; 1966 Nov; 48():2642-3. PubMed ID: 5979467 [No Abstract] [Full Text] [Related]
19. Frontiers in biological psychiatry: new drug development. Apter JT N J Med; 1993 Feb; 90(2):144-6. PubMed ID: 8464580 [TBL] [Abstract][Full Text] [Related]
20. An update on adolescent psychopharmacology. Katic A; Steingard RJ; Schmidt C Adolesc Med; 1998 Jun; 9(2):217-28. PubMed ID: 10961231 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]